By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...
AllAfrica on MSN
South Africa: Lenacapavir - a Game-Changer in South Africa's HIV Prevention Strategy
When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in January this year, we immediately set about finding solutions. Among the most pressing was to ...
The timing of the renewed support is pivotal. South Africa is preparing to roll out Lenacapavir, a groundbreaking long-acting ...
South Africa has made history by becoming the first African nation to register Lenacapavir, a revolutionary long-acting ...
Zacks.com on MSN
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report third-quarter 2025 result s on Oct. 30, after market close.
SAHPRA chief executive Dr Boitumelo Semete-Makokotlela said the product is “the most effective HIV prevention measure thus ...
Gilead Sciences reports Q3 earnings Oct 30. Discover estimates, analyst revisions, and past performance stats.
In recent weeks, Gilead Sciences announced Health Canada's conditional approval of LYVDELZI (seladelpar) for primary biliary ...
GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...
Self-Cav, South Africa’s AI chatbot on WhatsApp, empowers teens with 24/7 support on HIV prevention, PrEP, mental health, and ...
South Africa approved lenacapavir on October 21, 2025—a twice-yearly injection offering near-100% HIV protection. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results